Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Inflammatory Challenge Using Endotoxin

NCT04310423 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04310423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04310423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Inflammatory Challenge Using Endotoxin
Lead sponsor
University of California, Los Angeles
Phase
Phase 2
Overall status
Completed
Start date
October 19, 2021
Completion date
November 14, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, craving, depressed mood, inflammatory response